JP2024525959A5 - - Google Patents

Info

Publication number
JP2024525959A5
JP2024525959A5 JP2024504021A JP2024504021A JP2024525959A5 JP 2024525959 A5 JP2024525959 A5 JP 2024525959A5 JP 2024504021 A JP2024504021 A JP 2024504021A JP 2024504021 A JP2024504021 A JP 2024504021A JP 2024525959 A5 JP2024525959 A5 JP 2024525959A5
Authority
JP
Japan
Prior art keywords
peptide
acid sequence
amino acid
pharmaceutical composition
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024504021A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024525959A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/AU2022/050778 external-priority patent/WO2023000038A1/en
Publication of JP2024525959A publication Critical patent/JP2024525959A/ja
Publication of JP2024525959A5 publication Critical patent/JP2024525959A5/ja
Pending legal-status Critical Current

Links

JP2024504021A 2021-07-23 2022-07-22 ランチオニン合成酵素C様タンパク質(LanCL)に結合可能なペプチド組成物およびその使用 Pending JP2024525959A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2021902267A AU2021902267A0 (en) 2021-07-23 Compositions and uses thereof
AU2021902267 2021-07-23
PCT/AU2022/050778 WO2023000038A1 (en) 2021-07-23 2022-07-22 Peptide compositions capable of binding lanthionine synthetase c-like protein (lancl) and uses thereof

Publications (2)

Publication Number Publication Date
JP2024525959A JP2024525959A (ja) 2024-07-12
JP2024525959A5 true JP2024525959A5 (cg-RX-API-DMAC10.html) 2025-07-29

Family

ID=84980448

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024504021A Pending JP2024525959A (ja) 2021-07-23 2022-07-22 ランチオニン合成酵素C様タンパク質(LanCL)に結合可能なペプチド組成物およびその使用

Country Status (8)

Country Link
US (1) US20250263435A1 (cg-RX-API-DMAC10.html)
EP (1) EP4373509A4 (cg-RX-API-DMAC10.html)
JP (1) JP2024525959A (cg-RX-API-DMAC10.html)
KR (1) KR20240036634A (cg-RX-API-DMAC10.html)
CN (1) CN117813105A (cg-RX-API-DMAC10.html)
AU (1) AU2022316237A1 (cg-RX-API-DMAC10.html)
CA (1) CA3226259A1 (cg-RX-API-DMAC10.html)
WO (1) WO2023000038A1 (cg-RX-API-DMAC10.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7751583B2 (ja) * 2019-12-27 2025-10-08 ラテラル、アイピー、プロプライエタリー、リミテッド 環状ペプチド受容体ランチオニンシンテターゼc様タンパク質(lancl)及びその使用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6638911B1 (en) * 1998-05-05 2003-10-28 Adherex Technologies Inc. Compounds and methods for modulating desmosomal cadherin-mediated functions
AUPQ981700A0 (en) * 2000-09-01 2000-09-28 Metabolic Pharmaceuticals Limited Product and method for control of obesity
WO2007068039A1 (en) * 2005-12-12 2007-06-21 Metabolic Pharmaceuticals Limited Treatment of weight gain in estrogen deficient mammals
WO2009013621A2 (en) * 2007-05-30 2009-01-29 Auckland Uniservices Limited Inhibitors for growth hormone and related hormones, and methods of use thereof
WO2009094172A2 (en) * 2008-01-22 2009-07-30 Araim Pharmaceuticals, Inc. Tissue protective peptides and peptide analogs for preventing and treating diseases and disorders associated with tissue damage
CA3032944A1 (en) * 2016-08-05 2018-02-08 Sera Prognostics, Inc. Biomarkers for predicting preterm birth in a pregnant female exposed to progestogens
CN110546157A (zh) * 2017-02-22 2019-12-06 健康之语公司 筛查感染的方法
WO2019136528A1 (en) * 2018-01-15 2019-07-18 Lateral IP Pty Ltd Peptides and uses thereof
WO2019183686A1 (en) * 2018-03-29 2019-10-03 Lateral IP Pty Ltd Cyclic peptides and uses thereof
US11149256B2 (en) * 2018-09-26 2021-10-19 California Institute Of Technology Adeno-associated virus compositions for targeted gene therapy
EP3671210A1 (en) * 2018-12-21 2020-06-24 Biosystems International KFT Lung cancer protein epitomic biomarkers
JP7751583B2 (ja) * 2019-12-27 2025-10-08 ラテラル、アイピー、プロプライエタリー、リミテッド 環状ペプチド受容体ランチオニンシンテターゼc様タンパク質(lancl)及びその使用
RU2731919C1 (ru) * 2020-03-25 2020-09-09 Федеральное государственное автономное образовательное учреждение высшего образования "Белгородский государственный национальный исследовательский университет" (НИУ "БелГУ") Способ коррекции микроциркуляции в плаценте пептидом, имитирующим альфа-спираль B эритропоэтина, при ADMA-подобной модели преэклампсии
RU2751964C1 (ru) * 2021-02-17 2021-07-21 Федеральное государственное автономное образовательное учреждение высшего образования "Белгородский государственный национальный исследовательский университет" (НИУ "БелГУ") Способ снижения агрегационной способности тромбоцитов

Similar Documents

Publication Publication Date Title
JP2025166834A5 (cg-RX-API-DMAC10.html)
IL262805B2 (en) Agonist agents of cd47 inducing programmed cell death and their use in the treatments of diseases associated with defects in programmed cell death
JP2008536483A5 (cg-RX-API-DMAC10.html)
JP2004525608A5 (cg-RX-API-DMAC10.html)
JP2007535910A5 (cg-RX-API-DMAC10.html)
JP2023541798A5 (cg-RX-API-DMAC10.html)
HRP20240906T1 (hr) Agonisti crf2 receptora i njihova primjena u terapiji
JP2004537581A5 (cg-RX-API-DMAC10.html)
JP2010508030A5 (cg-RX-API-DMAC10.html)
JP2023551122A5 (cg-RX-API-DMAC10.html)
JP2025512515A5 (cg-RX-API-DMAC10.html)
JP2020117504A5 (cg-RX-API-DMAC10.html)
JP2008521795A5 (cg-RX-API-DMAC10.html)
JP2005502332A5 (cg-RX-API-DMAC10.html)
JP2025063151A5 (cg-RX-API-DMAC10.html)
JP2022539560A5 (cg-RX-API-DMAC10.html)
JP2005511038A5 (cg-RX-API-DMAC10.html)
JP2020515283A5 (cg-RX-API-DMAC10.html)
JP2025512749A5 (cg-RX-API-DMAC10.html)
JP2008517998A5 (cg-RX-API-DMAC10.html)
ES2349153T3 (es) Inhibidores del virus de la hepatitis c.
JP2003522185A5 (cg-RX-API-DMAC10.html)
JP2021531246A5 (cg-RX-API-DMAC10.html)
JPWO2023282281A5 (cg-RX-API-DMAC10.html)
IL115682A0 (en) Cryptdin peptides methods for the preparation thereof and pharmaceutical compostions containing the same